<SEC-DOCUMENT>0001104659-24-050589.txt : 20240423
<SEC-HEADER>0001104659-24-050589.hdr.sgml : 20240423
<ACCEPTANCE-DATETIME>20240423161549
ACCESSION NUMBER:		0001104659-24-050589
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20240423
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240423
DATE AS OF CHANGE:		20240423

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TACTILE SYSTEMS TECHNOLOGY INC
		CENTRAL INDEX KEY:			0001027838
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37799
		FILM NUMBER:		24865004

	BUSINESS ADDRESS:	
		STREET 1:		1331 TYLER STREET NE STE 200
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55413
		BUSINESS PHONE:		866-435-3948

	MAIL ADDRESS:	
		STREET 1:		1331 TYLER STREET NE STE 200
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55413
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2412326d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:TCMD="http://tactilemedical.com/20240423">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_039_TCMD_tactilemedical.com_20240423 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20240423_20240423 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001027838 -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000004" name="dei:EntityCentralIndexKey">0001027838</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-04-23" id="xdx2ixbrl0012" name="dei:EntityRegistrantName">TACTILE SYSTEMS TECHNOLOGY INC</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="tcmd-20240423.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-04-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001027838</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-23</xbrli:startDate>
        <xbrli:endDate>2024-04-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90D_edei--DocumentType_c20240423__20240423_zxR6fXHgZ3N4"><ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported)
<b>&#160;<span id="xdx_903_edei--DocumentPeriodEndDate_c20240423__20240423_zYSFryIZowae"><ix:nonNumeric contextRef="AsOf2024-04-23" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">April 23, 2024</ix:nonNumeric></span></b></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 2in 2pt; text-align: center"><b>&#160;</b></p>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_907_edei--EntityRegistrantName_dxL_c20240423__20240423_zFIAIrnbfkqd" title="::XDX::TACTILE%20SYSTEMS%20TECHNOLOGY%20INC"><b><span style="-sec-ix-hidden: xdx2ixbrl0012">TACTILE
SYSTEMS TECHNOLOGY, INC.</span></b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 2in 2pt; text-align: center">(Exact name
of registrant as specified in its charter)</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>




<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20240423__20240423_znvj4GF3dEze"><ix:nonNumeric contextRef="AsOf2024-04-23" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span id="xdx_901_edei--EntityFileNumber_c20240423__20240423_zrFu2wWkLrV7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000014" name="dei:EntityFileNumber">001-37799</ix:nonNumeric></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 33%"><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20240423__20240423_zhqKsxl40bw8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000015" name="dei:EntityTaxIdentificationNumber">41-1801204</ix:nonNumeric></b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_908_edei--EntityAddressAddressLine1_c20240423__20240423_zcCcddrepNe1"><b><ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000016" name="dei:EntityAddressAddressLine1">3701
Wayzata Blvd</ix:nonNumeric></b></span><b>, <span id="xdx_90E_edei--EntityAddressAddressLine2_c20240423__20240423_zBIQB7We0ZVg"><ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000017" name="dei:EntityAddressAddressLine2">Suite 300</ix:nonNumeric></span></b><b>,
<span id="xdx_90A_edei--EntityAddressCityOrTown_c20240423__20240423_zrE1pr4zGDs9"><ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000018" name="dei:EntityAddressCityOrTown">Minneapolis</ix:nonNumeric></span></b><b>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20240423__20240423_zlwGQk1v6FBg"><ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000019" name="dei:EntityAddressStateOrProvince">MN</ix:nonNumeric>
</span></b><b><span id="xdx_90B_edei--EntityAddressPostalZipCode_c20240423__20240423_zJQMzvLxilo6"><ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000020" name="dei:EntityAddressPostalZipCode">55416</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices) (Zip
Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_909_edei--CityAreaCode_c20240423__20240423_zYchDpmCIkyd"><ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000021" name="dei:CityAreaCode">612</ix:nonNumeric></span></b><b>)
<span id="xdx_908_edei--LocalPhoneNumber_c20240423__20240423_zXzCBDhCMXw4"><ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000022" name="dei:LocalPhoneNumber">355-5100</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_909_edei--WrittenCommunications_c20240423__20240423_zDeBrB3TzCF5" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2024-04-23" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span>&#160;Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_90B_edei--SolicitingMaterial_c20240423__20240423_zQ7J5qfM3nu4" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2024-04-23" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span>&#160;Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in"><span id="xdx_904_edei--PreCommencementTenderOffer_c20240423__20240423_zlx8FG65Lb8g" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2024-04-23" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span>&#160;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20240423__20240423_zy5tuF25AJw2" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2024-04-23" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span>&#160;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Securities registered
pursuant to Section 12(b) of the Act:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which <br/>
    registered</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_edei--Security12bTitle_c20240423__20240423_zxjfaEUiOyDd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000027" name="dei:Security12bTitle">Common
    Stock, Par Value $0.001 Per Share</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_904_edei--TradingSymbol_c20240423__20240423_z6gXNsKiKq4b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-04-23" id="Fact000028" name="dei:TradingSymbol">TCMD</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_edei--SecurityExchangeName_c20240423__20240423_zhC8Vejy7tpg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-04-23" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;&#160;<span id="xdx_904_edei--EntityEmergingGrowthCompany_c20240423__20240423_zOIkTl5ILMk" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2024-04-23" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric>
</span>Emerging growth company</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 2.02. Results of Operations and Financial
Condition.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">On
April&#160;23, 2024, </span><span style="color: #212529">Tactile Systems Technology,&#160;Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221;
&#8220;us&#8221; or &#8220;our&#8221;) i</span>ssued a press release disclosing its <span style="color: #212529">preliminary</span> estimated
revenue results for the fiscal quarter ended March&#160;31, 2024.&#160; A copy of the press release is attached hereto as Exhibit&#160;99.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with General
Instruction B.2 of Form&#160;8-K, the information in this Item 2.02, including Exhibit&#160;99.1, shall not be deemed to be &#8220;filed&#8221;
for purposes of Section&#160;18 of the Securities Exchange Act of 1934 or otherwise subject to the liability of that section, and shall
not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Securities
Exchange Act of 1934, except as shall be expressly set forth by specific reference in that filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Item 5.02. </b></span><b>Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; color: #212529">On
April&#160;23, 2024, the Company announced that Daniel L. Reuvers has informed the Company&#8217;s </span><span style="background-color: white">Board
of Directors of his decision to retire as Chief Executive Officer, effective as of June&#160;30, 2024, and that the Board of Directors
has </span><span style="color: #212529">appointed Sheri L. Dodd as the Company&#8217;s Chief Executive Officer, effective July&#160;1,
2024 (the &#8220;Effective Date&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529"><i><span style="text-decoration: underline">Ms.&#160;Dodd</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; color: #212529">Ms.&#160;Dodd
has been a member of the Company&#8217;s Board of Directors since January&#160;1, 2021, and will remain on the Board following the Effective
Date, assuming the Company&#8217;s stockholders re-elect her as a director at the 2024 Annual Meeting of Stockholders to be held on May&#160;8,
2024. Ms.&#160;Dodd is no longer a member of any of the committees of the Board, and William W. Burke has taken her place as a member
of the C</span>ompliance and Reimbursement Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">Ms.&#160;Dodd,</span>
<span style="color: #212529">age 58, most</span>&#160;recently served as President of Medtronic Canada at Medtronic, plc. Since joining
Medtronic in March&#160;2010,&#160;Ms.&#160;Dodd served as Vice President and General Manager of Medtronic Care Management Services, Vice
President and General Manager of Non-intensive Diabetes Therapies and Vice President for Global health economics, reimbursement&#160;&amp;
policy and global clinical research across the Medtronic cardiovascular portfolio.&#160; From November&#160;1997 until March&#160;2010,
Ms.&#160;Dodd held various positions in the <span style="background-color: white">pharma</span> and medical devices divisions with Johnson&#160;&amp;
Johnson, most recently as vice president of health economics and <span style="color: #212529">reimbursement</span> for Ethicon,&#160;Inc.
Ms.&#160;Dodd also served as an outcomes researcher with Orthopedic Surgeons, plc from January&#160;1995 until November&#160;1997. From
May&#160;1988 until September&#160;1993, Ms.&#160;Dodd served as a project coordinator with the World Health <span style="color: #212529">Organization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #212529">There are
no arrangements or understandings between Ms.&#160;Dodd and any other persons pursuant to which she was appointed our Chief Executive
Officer. There are no family relationships between Ms.&#160;Dodd and any of our directors or executive officers, and Ms.&#160;Dodd does
not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a)&#160;of Regulation
S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #212529">Ms.&#160;Dodd
and the Company entered into an offer letter dated April&#160;23, 2024. In addition, the Compensation and Organization Committee of the
Board of Directors approved Ms.&#160;Dodd&#8217;s initial compensation as Chief Executive Officer as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; color: #212529">An initial&#160;</span><span style="font-family: Times New Roman, Times, Serif">annual
base salary of $650,000 per year.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: #212529">Ms.&#160;Dodd</span> <span style="font-family: Times New Roman, Times, Serif">will
be eligible to receive an annual cash bonus under the Company&#8217;s management incentive plan in a target amount equal to 90% of her
actual base salary earned for 2024.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: #212529">Ms.&#160;Dodd</span> <span style="font-family: Times New Roman, Times, Serif">will
receive equity awards under our 2016 Equity Incentive Plan, to be granted on the second business day following our release of earnings
for the second fiscal quarter of 2024:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-size: 10pt; color: #212529">o</span></td><td style="text-align: justify">a grant of restricted stock units (&#8220;RSUs&#8221;) with a value of $875,000, which RSUs will vest
in thirds over the first three anniversaries of the date of grant; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-size: 10pt; color: #212529">o</span></td><td style="text-align: justify"><span style="color: #212529">a grant of performance stock units (&#8220;PSUs&#8221;) with a value of $850,000,
which PSUs will be earned and </span>vested <span style="color: #212529">over three years consistent with the PSUs granted to the Company&#8217;s
other executive officers in 2024.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: #212529">Ms.&#160;Dodd will be&#160;</span><span style="font-family: Times New Roman, Times, Serif">entitled
to participate in all employee benefit plans and programs to the extent that she meets the eligibility requirements for each individual
plan or program.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: #212529">Ms.&#160;Dodd </span><span style="font-family: Times New Roman, Times, Serif">will
enter into our standard Confidentiality, Assignment of Intellectual Property and Restrictive Covenants Agreement (the &#8220;Restrictive
Covenants Agreement&#8221;), and then become a participant in our Executive Employee Severance Plan (the &#8220;Executive Severance Plan&#8221;)
at the Chief Executive Officer level of benefits.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; color: #212529">A
copy of the offer letter and the form Restrictive Covenants Agreement are filed as Exhibit&#160;10.1 and Exhibit&#160;10.2, respectively,
to this report and are incorporated herein by reference. A summary of the Executive Severance Plan is included in our Proxy Statement
for our 2024 Annual Meeting of Stockholders, which was filed with the Securities and Exchange Commission on March&#160;27, 2024 under
&#8220;Executive Compensation &#8211; Potential Payments Upon Termination or Change in Control &#8211; Severance Plan.&#8221; The Executive
Severance Plan was filed as&#160;</span>Exhibit&#160;10.2<span style="color: #212529">&#160;to our&#160;</span>Quarterly Report on Form&#160;10-Q
filed November&#160;5, 2018&#160;<span style="color: #212529">and is incorporated herein by reference as Exhibit&#160;10.3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><i><span style="text-decoration: underline">Mr.&#160;Reuvers</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; color: #212529">In
connection with Mr.&#160;Reuvers&#8217; planned retirement, the Company and Mr.&#160;Reuvers entered into a Transition Letter Agreement,
dated as of April&#160;23, 2024 (the &#8220;Transition Agreement&#8221;). The Transition Agreement provides that Mr.&#160;Reuvers will
continue to </span>serve as the Company&#8217;s Chief Executive Officer through June&#160;30, 2024, with the same compensatory and other
terms as are currently in effect. However, as a result of Mr.&#160;Reuvers&#8217; voluntary retirement, he will not be eligible to earn
or receive any payment under the Company&#8217;s annual executive bonus plan or any other form of cash incentive compensation for 2024,
and his voluntary retirement will not make him eligible to receive any payments or benefits under the Executive Severance Plan or under
any other Company severance plan or program.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; color: #212529">The
Transition Agreement provides that, effective on the Effective Date, Mr.&#160;</span>Reuvers will continue to be employed by the Company
as an Advisor to the Chief Executive Officer through March&#160;31, 2025, which will be a non-executive role that includes providing transitional
and operational assistance. In such <span style="color: #212529">role</span>, Mr.&#160;Reuvers will be paid an annualized salary of $525,000,
subject to applicable withholdings, and will not be eligible to earn or receive any form of cash incentive compensation for 2024 or any
subsequent year or to receive any additional equity grants for 2024 or any subsequent year. The Transition Agreement also provides that
if Mr.&#160;Reuvers becomes ineligible for continued medical, dental or vision coverage under the Company-sponsored plans, then the Company
will pay the portion of the premium costs for such coverage under COBRA through the earlier of December&#160;31, 2025 or the date he is
no longer eligible to continue COBRA coverage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following the Effective Date,
Mr.&#160;Reuvers will <span style="color: #212529">remain on the Board, assuming the Company&#8217;s stockholders re-elect him as a director
at the 2024 Annual Meeting of Stockholders to be held on May&#160;8, 2024. The Transition Agreement provides that </span>Mr.&#160;<span style="color: #212529">Reuvers</span>
will not receive any compensation for his Board service through the 2025 Annual Meeting of Stockholders or any subsequent period that
he remains employed by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transition Agreement also
provides that the equity awards currently held by Mr.&#160;Reuvers will continue to be governed by the <span style="color: #212529">terms</span>
and conditions set forth in the applicable award agreements, including that his equity awards will remain outstanding and continue to
vest through the end of his employment or other service with the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #212529">The foregoing
summary of the Transition Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of
the Transition Agreement, a copy of which is filed as Exhibit&#160;10.4 to this report and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 7.01. Regulation
FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 10pt; background-color: white">On&#160;April&#160;23,
2024, the Company issued a press release related to the transition discussed in Item 5.02 above. A copy of this press release is furnished
as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K. The information in Exhibit&#160;99.1 </span>shall not be deemed to be &#8220;filed&#8221;
for purposes of Section&#160;18 of the Securities Exchange Act of 1934 or otherwise subject to the liability of that section, and shall
not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Securities
Exchange Act of 1934, except as shall be expressly set forth by specific reference in that filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXHIBIT&#160;INDEX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br/> No.</b></span></td>
<td style="text-align: center; width: 2%">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: center; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
<tr>
<td style="vertical-align: top"><a href="tm2412326d1_ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"><a href="tm2412326d1_ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offer Letter between Sheri L. Dodd and Tactile Systems Technology,&#160;Inc. dated April&#160;23, 2024</span></a></td></tr>
<tr>
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top">&#160;</td></tr>
<tr>
<td style="vertical-align: top"><a href="tm2412326d1_ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></a></td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"><a href="tm2412326d1_ex10-2.htm">Form&#160;of Confidentiality, Assignment of Intellectual Property and Restrictive Covenants Agreement &#160;</a></td></tr>
<tr>
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top">&#160;</td></tr>
<tr>
<td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1027838/000155837018008484/tcmd-20180930ex10287f7e7.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></a></td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1027838/000155837018008484/tcmd-20180930ex10287f7e7.htm" style="-sec-extract: exhibit">Tactile Systems Technology,&#160;Inc. Executive Employee Severance Plan (incorporated herein by reference to Exhibit&#160;10.2 to the Company&#8217;s Quarterly Report on Form&#160;10-Q filed November&#160;5, 2018) &#160;</a></td></tr>
<tr>
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top">&#160;</td></tr>
<tr>
<td style="vertical-align: top"><a href="tm2412326d1_ex10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></a></td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"><a href="tm2412326d1_ex10-4.htm">Transition Letter Agreement between Daniel L. Reuvers and Tactile Systems Technology,&#160;Inc. dated April&#160;23, 2024 &#160;</a></td></tr>
<tr>
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top">&#160;</td></tr>
<tr>
<td style="vertical-align: top"><a href="tm2412326d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"><a href="tm2412326d1_ex99-1.htm">Press Release dated April&#160;23, 2024 &#160;</a></td></tr>
<tr>
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top">&#160;</td></tr>
<tr>
<td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TACTILE SYSTEMS TECHNOLOGY,&#160;INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td></tr>
  <tr>
    <td style="width: 50%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: </span><span style="font-family: Times New Roman, Times, Serif">April 23, 2024</span></td>
    <td style="vertical-align: top; width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 47%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <i>Elaine M. Birkemeyer</i></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elaine M. Birkemeyer</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2WUq3esjHxCKyCInodckxlnRHZrfST+ov25RoGBiGe8+9QoRiQ2tdI8NlVeRwwqatlUMosEJGc0XvSLe7BPwt8KatY2Xc8P7AlDyDnllMpFReGKxPbbFMIJpP4+VUziFaJnIGx70IvnpKptIlGqdVDcqUcGRqWaNT3I8JJ9WRoaYfqs7IVpNJIJ5Eo/wGGcUSDvRUL+K7hTxPRRAOE4gN06P1rqxzaL4kZDU2vs6O9H+DDwsKSpQ= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2412326d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT><B>Exhibit&nbsp;10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April&nbsp;23, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sheri Dodd (By E-mail)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Sheri:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are pleased to offer you the full-time position as Chief Executive
Officer at Tactile Systems Technology,&nbsp;Inc. (the &ldquo;Company&rdquo;). Your employment start date is June&nbsp;30, 2024, and you
will become the Company&rsquo;s Chief Executive Officer and Assistant Secretary effective July&nbsp;1, 2024. This employment offer is
conditioned on you countersigning and returning this conditional employment offer letter, the satisfactory completion of a background
check and on you signing and returning the enclosed Confidentiality, Assignment of Intellectual Property and Restrictive Covenants Agreement
on or before your employment start date. In addition, you will be required to provide the Company with required valid documents for Employment
Eligibility Verification (I-9 form) within three days after your employment start date as required by the Immigration Reform and Control
Act of 1986.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You will be a full-time exempt employee reporting to the Company&rsquo;s
Board of Directors (the &ldquo;Board&rdquo;) and the Compensation&nbsp;&amp; Organization Committee of the Board will determine your compensation.
You will not be required to relocate your personal residence to be near the Company&rsquo;s corporate headquarters, but your duties and
responsibilities will require regular travel, including working from the Company&rsquo;s corporate headquarters and other locations as
appropriate. You will be reimbursed for business-related expenses in accordance with the Company&rsquo;s relevant expense reimbursement
policies and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You will be eligible for health and welfare benefits on the first of
the month following your employment start date. You will receive information on the insurance plans and enrollment materials on your first
day of employment. Other benefits for which you may be eligible, including but not limited to 401(k)&nbsp;and Employee Stock Purchase
Plan, will be addressed in the Company&rsquo;s Employee Handbook and/or during your new hire orientation. The company&rsquo;s benefit
plans and programs may change from time to time and the company provides no assurance as to the adoption or continuation of any particular
employee benefit plan or program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You also are eligible for time away benefits including Reasonable Time
Off, Jury Duty, Parental and Bereavement. The terms of use for your leave benefits are available to review in the Company&rsquo;s Employee
Handbook.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please sign and return this offer letter to confirm
your acceptance of this offer of employment with the Company. By signing below, you confirm that you do not have any type of written or
oral non-solicitation or non-competition agreement, or any other agreement, which would prevent you from accepting or performing services
for the Company. You agree that you will not use or disclose confidential information obtained from previous employers during your employment
with the Company, unless the information is publicly known or your previous employers have represented to you that you are entitled to
use or disclose the information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As you know, the Company offers a great culture and wonderful opportunities
to expand your expertise. It is a very exciting time for our entire organization, and we are happy that you have chosen to be a part of
it!</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2412326d1_ex10-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ William W. Burke</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Elaine Birkemeyer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William W. Burke</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elaine Birkemeyer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair, Board of Directors</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enclosure:</FONT></TD>
    <TD STYLE="width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidentiality, Assignment of Intellectual Property and Restrictive Covenants Agreement</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acknowledged and Agreed To:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sheri Dodd</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sheri Dodd</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April&nbsp;23, 2024</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2412326d1_ex10-1img002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tm2412326d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>TACTILE
SYSTEMS TECHNOLOGY,&nbsp;INC.<BR>
Confidentiality, Assignment of Intellectual Property and<BR>
Restrictive Covenants Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Confidentiality, Assignment of Intellectual
Property and Restrictive Covenants Agreement (together with <U>Exhibit&nbsp;A</U> and <U>Exhibit&nbsp;B</U>, this &ldquo;<B>Agreement</B>&rdquo;),
entered into effective [_________________], 20[__] (the &ldquo;<B>Effective Date</B>&rdquo;), is intended to formalize in writing certain
understandings and procedures which are and will be in effect during the time [_____________] (&ldquo;<B>Employee</B>&rdquo;) is employed
by Tactile Systems Technology,&nbsp;Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;). In consideration of employment by
the Company, the compensation and benefits Employee receives in connection with such employment, Company providing Employee with access
to Company Proprietary Information, and other good and valuable consideration, Employee and Company agree as follows (as modified by <U>Exhibit&nbsp;A</U>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><U>At-Will Employment; No Conflict.</U> Employee will perform for the Company such duties as may be designated
by the Company from time to time. Employee agrees that Employee&rsquo;s employment with the Company is for no specified term and may be
terminated by the Company at any time, with or without cause, and with or without notice. Similarly, Employee may terminate employment
with the Company at any time, with or without cause and with or without notice. During Employee&rsquo;s period of employment by the Company,
Employee will devote Employee&rsquo;s best efforts to the interests of the Company and will not engage in other employment or in any activities
determined by the Company to be detrimental to the best interests of the Company without the prior written consent of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><U>Prior Work.</U> All previous work, if any, done by Employee for the Company relating in any way to
the conception, design, development or support of products for the Company is the property of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><U>Proprietary Information.</U> Employee&rsquo;s employment creates a relationship of confidence and trust
in the Employee for the benefit of the Company with respect to any information:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">a.</TD><TD STYLE="text-align: justify">Applicable to the business of the Company, including the development, sale, service, or distribution of
medical devices to treat lymphedema patients or any other business applicable to the Company or its Affiliates (as defined below); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">b.</TD><TD STYLE="text-align: justify">Applicable to the business of any client or customer of the Company, which may be disclosed to Employee
by the Company or by any client or customer of the Company or learned by Employee in such context during the period of Employee&rsquo;s
employment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">All of such information has commercial
value in the business in which Company is engaged and is referred to as &ldquo;<B>Company Proprietary Information</B>&rdquo; in this Agreement.
By way of illustration, but not limitation, Company Proprietary Information includes trade secrets, any and all technical and non-technical
information including patent, copyright, trade secret, and proprietary information, techniques, sketches, drawings, models, inventions,
know-how, processes, apparatus, equipment, algorithms, software programs, software source documents, and formulae related to the current,
future and proposed products and services of Company, and includes, without limitation, its respective information concerning research,
experimental work, development, design details and specifications, engineering, financial information, procurement requirements, purchasing
manufacturing, customer lists, business forecasts, sales and merchandising and marketing plans and information. Employee acknowledges
that the above-described knowledge and information constitutes a unique and valuable asset of the Company and represents a substantial
investment of time and expense by the Company, and that any disclosure or other use of such knowledge or information other than for the
sole benefit of the Company or its Affiliates would be wrongful and would cause irreparable harm to the Company. Employee will refrain
from intentionally committing any acts that would materially reduce the value of such knowledge or information to the Company or its Affiliates.
Company Proprietary Information shall not include information that is generally available to and known by the public, provided that such
disclosure to the public is through no direct or indirect fault of Employee or person(s)&nbsp;acting on Employee&rsquo;s behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">As used in this Agreement, &ldquo;<B>Third
Party Proprietary Information</B>&rdquo; includes proprietary or confidential information of any third party who may disclose such information
to Company or Employee in the course of Company&rsquo;s business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">As used in this Agreement, &ldquo;<B>Affiliates</B>&rdquo;
includes the Company and each corporation, partnership, or other entity which controls the Company, is controlled by the Company, <FONT STYLE="font-variant: small-caps"><U>or</U></FONT>
is under common control with the Company (in each case &ldquo;<B>control</B>&rdquo; meaning the direct or indirect ownership of 50% or
more of all outstanding equity interests).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><U>Nondisclosure of Proprietary Information.</U> All Company Proprietary Information is the sole property
of the Company, its assigns, and the Company, its assigns and its customers will be the sole owner of all patents, copyrights, maskworks,
trade secrets and other rights in connection therewith. Employee hereby assigns to the Company any rights Employee may have or acquire
in such Company Proprietary Information. At all times, both during Employee&rsquo;s employment by the Company and after termination of
such employment, Employee will keep in confidence and trust all Company and Third Party Proprietary Information, and Employee will not
use or disclose any Company or Third Party Proprietary Information or anything directly relating to it without the written consent of
the Company, except as may be necessary in the ordinary course of performing Employee&rsquo;s duties as an employee of the Company. Notwithstanding
the foregoing, it is understood that, at all such times, Employee is free to use information which is generally known in the trade or
industry not as a result of a breach of this Agreement. Employee understands and agrees that Employee&rsquo;s obligations under this Agreement
to maintain the confidentiality of the Company&rsquo;s confidential information are in addition to any obligations of Employee under applicable
statutory or common law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Outside of employment by the Company and
after termination of employment with Company, Employee may use the general skill, knowledge, know-how and experience acquired during employment
with the Company, provided that such use (1)&nbsp;does not relate (a)&nbsp;directly to the business of the Company or (b)&nbsp;to the
Company&rsquo;s actual or demonstrably anticipated research or development, (2)&nbsp;does not result from any work performed by Employee
for the Company, or (3)&nbsp;is required to be disclosed by law or legal process. In addition, the foregoing obligations of confidentiality
shall not apply to any knowledge or information that (i)&nbsp;is now or subsequently becomes generally publicly known, other than as a
direct or indirect result of the breach of this Agreement, (ii)&nbsp;is independently made available to Employee in good faith by a third
party who has not violated a confidential relationship with the Company or its Affiliates, or (iii)&nbsp;is required to be disclosed by
law or legal process. In addition, notwithstanding any other language in this Agreement, nothing in this <U>Section&nbsp;4</U> or otherwise
in this Agreement is intended to prohibit Employee from providing information to a governmental agency, participating in an investigation
or proceeding conducted by a governmental agency, or discussing or disclosing terms and conditions of employment or otherwise exercising
any rights Employee has under Section&nbsp;7 of the National Labor Relations Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify"><U>Defend Trade Secrets Act</U>. Employee understands that pursuant to the Defend Trade Secrets Act of
2016 (&ldquo;<B>DTSA</B>&rdquo;), Employee shall not be held criminally, or civilly, liable under any federal or state trade secret law
for disclosing a trade secret that is made in confidence either directly or indirectly to a federal, state, or local government official,
or an attorney, for the sole purpose of reporting or investigating a violation of law. Moreover, Employee understands that Employee may
disclose trade secrets in a complaint or other document filed in a lawsuit or other proceeding if such filing is made under seal. If Employee
files a lawsuit alleging retaliation by the Company for reporting a suspected violation of the law Employee may disclose the trade secret
to Employee&rsquo;s attorney and use the trade secret in the court proceeding, provided Employee files any document containing the trade
secret under seal and does not disclose the trade secret, except pursuant to court order. <B>Employee understands that any unauthorized
disclosure of the Company&rsquo;s trade secrets that is not properly made under the DTSA can subject Employee to severe criminal and civil
penalties</B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><U>Return of Materials.</U> Upon termination of Employee&rsquo;s employment or at any time upon the Company&rsquo;s
request, Employee will promptly deliver to the Company any and all Company and Affiliate records and any and all Company and Affiliate
property in Employee&rsquo;s possession or under Employee&rsquo;s control, including without limitation manuals, books, blank forms, documents,
letters, memoranda, notes, notebooks, reports, printouts, computer disks, computer tapes, source codes, data, tables or calculations and
all copies thereof, documents that in whole or in part contain any trade secrets or confidential, proprietary or other secret information
of the Company or its Affiliates, or any Third Party Proprietary Information, and all copies thereof, and keys, access cards, access codes,
passwords, credit cards, personal computers, telephones and other electronic equipment belonging to the Company or its Affiliates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify"><U>Inventions,&nbsp;Ideas, and Expressions of Ideas.</U> As used in this Agreement, the term &ldquo;<B>Inventions,&nbsp;Ideas,
and Expression of Ideas</B>&rdquo; means any and all new or useful art, discovery, improvement, technical development, or invention whether
or not patentable, and all related know-how, designs, maskworks, trademarks, formulae, processes, manufacturing techniques, trade secrets,
ideas, artwork, software or other copyrightable or patentable works.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify"><U>Disclosure of Prior Inventions.</U> Employee has identified on <U>Exhibit&nbsp;B</U> all Inventions,&nbsp;Ideas,
and Expressions of Ideas relating in any way to the Company&rsquo;s business or demonstrably anticipated research and development that
were made by Employee prior to employment with the Company (&ldquo;<B>Prior Inventions,&nbsp;Ideas, and Expressions of Ideas</B>&rdquo;),
and Employee represents that such list is complete. Employee represents that Employee has no rights in any such Inventions,&nbsp;Ideas,
and Expressions of Ideas other than those Prior Inventions,&nbsp;Ideas, and Expressions of Ideas specified in <U>Exhibit&nbsp;B</U>. If
there is no such list on <U>Exhibit&nbsp;B</U>, Employee represents that Employee has made no such Prior Inventions,&nbsp;Ideas, and Expressions
of Ideas at the time of signing this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><U>Ownership of Company Inventions; License of Prior Inventions.</U> Employee acknowledges that all original
works of authorship that are made by Employee (solely or jointly with others) within the scope of employment and that are protectable
by copyrights are &ldquo;works made for hire&rdquo; as that term is defined in the United States Copyright Act (17 USA 101). Employee
hereby agrees promptly to disclose and describe to the Company, and hereby assigns and agrees to assign to the Company or its designee,
Employee&rsquo;s entire right, title, and interest in and to all Inventions,&nbsp;Ideas, and Expressions of Ideas and any associated intellectual
property rights that Employee may solely or jointly conceive, develop or reduce to practice during the period of employment with the Company
(a)&nbsp;that relate at the time of conception or reduction to practice of the invention to the Company&rsquo;s business or actual or
demonstrably anticipated research or development, or (b)&nbsp;that were developed on any amount of the Company&rsquo;s time or with the
use of any of the Company&rsquo;s equipment, supplies, facilities or trade secret information, or (c)&nbsp;that resulted from any work
Employee performed for the Company (&ldquo;<B>Company Inventions</B>&rdquo;). Employee agrees to grant the Company or its designees a
royalty free, irrevocable, worldwide license (with rights to sublicense through multiple tiers of distribution) to practice all applicable
patent, copyright and other intellectual property rights relating to any Prior Inventions,&nbsp;Ideas, and Expressions of Ideas that Employee
incorporates, or permits to be incorporated, in any Company Inventions. Notwithstanding the foregoing, Employee agrees that Employee will
not incorporate, or permit to be incorporated, such Prior Inventions,&nbsp;Ideas, and Expressions of Ideas in any Company Inventions without
Company&rsquo;s prior written consent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify"><U>Future Inventions.</U> Employee recognizes that Company Inventions or Company Proprietary Information
relating to Employee&rsquo;s activities while working for the Company and conceived or made by Employee, alone or with others, within
one year after termination of employment may have been conceived in significant part while employed by the Company. Accordingly, Employee
agrees that such post-employment inventions and proprietary information will be presumed to have been conceived during employment with
the Company and are to be assigned and are hereby assigned to the Company unless and until Employee has established the contrary.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify"><U>Cooperation in Perfecting Rights to Inventions.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">a.</TD><TD STYLE="text-align: justify">Employee agrees to perform, during and after employment, all acts deemed necessary or desirable by the
Company to permit and assist it, at its expense, in obtaining and enforcing the full benefits, enjoyment, rights and title throughout
the world in the Inventions,&nbsp;Ideas, and Expressions of Ideas hereby assigned to the Company. Such acts may include, but are not limited
to, execution of documents and assistance or cooperation in the registration and enforcement of applicable patents, copyrights, maskworks
or other legal proceedings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">b.</TD><TD STYLE="text-align: justify">In the event that the Company is unable for any reason to secure my signature to any document required
to apply for or execute any patent, copyright, maskwork or other applications with respect to any Inventions,&nbsp;Ideas, and Expressions
of Ideas (including improvements, renewals, extensions, continuations, divisions or continuations in part thereof), Employee hereby irrevocably
designates and appoints the Company and its duly authorized officers and agents as Employee&rsquo;s agents and attorneys-in-fact to act
for and on my behalf and instead of Employee, to execute and file any such application and to do all other lawfully permitted acts to
further the prosecution and issuance of patents, copyrights, maskworks or other rights thereon with the same legal force and effect as
if executed by Employee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify"><U>Agreement Not to Compete.</U> During Employee&rsquo;s employment with the Company or any Affiliates
of the Company and for a period of twelve (12) consecutive months from and after the termination of Employee&rsquo;s employment, whether
such termination is with or without cause, or whether such termination is at the instance of Employee or the Company, Employee will not,
directly or indirectly, engage in any business, in the United States or in any other location in which the Company is then doing business
(the &ldquo;<B>Restricted Territory</B>&rdquo;), for the development, sale, service, or distribution of medical devices to treat lymphedema
patients or any similar business that is competitive with the businesses of the Company or its Affiliates, including without limitation
as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise.
Ownership by Employee, as a passive investment, of less than 2.5% of the outstanding shares of capital stock of any corporation listed
on a national securities exchange or publicly traded in the over-the-counter market shall not constitute a breach of this <U>Section&nbsp;12</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify"><U>Agreement Not to Solicit or Hire.</U> During Employee&rsquo;s employment with the Company or any Affiliates
of the Company and for a period of twelve (12) consecutive months from and after the termination of Employee&rsquo;s employment, whether
such termination is with or without cause, or whether such termination is at the instance of Employee or the Company, Employee will not,
except on behalf of the Company, directly or indirectly, solicit, hire or engage any person who is then an employee or contractor of the
Company or who was an employee of the Company at any time during the six (6)&nbsp;month period immediately preceding Employee&rsquo;s
termination of employment, in any manner or capacity, including without limitation as a proprietor, principal, agent, partner, officer,
director, stockholder, employee, member of any association, consultant or otherwise, or otherwise directly or indirectly request, advise
or induce any then current employee or contractor of the Company to terminate or otherwise adversely change its relationship with the
Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify"><U>Agreement Not to Solicit.</U> During Employee&rsquo;s employment with the Company or any Affiliates
of the Company and for a period of twelve (12) consecutive months from and after the termination of Employee&rsquo;s employment, whether
such termination is with or without cause, or whether such termination is at the instance of Employee or the Company, Employee will not,
except on behalf of the Company, directly or indirectly, in any manner or capacity, including without limitation a proprietor, principal,
agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise, in the Restricted Territory:
(i)&nbsp;call on or solicit any customers of the Company, including but not limited to any customers of the Company with which Employee
had contact during the then-prior twenty-four (24) month period or about which Employee had Confidential Information, for the purpose
of marketing or selling any products or services competitive with or otherwise substantially similar to the then-current businesses of
the Company, or for the purpose of diverting any business away from the Company; (ii)&nbsp;persuade or attempt to persuade, or induce
or attempt to induce, any actual or prospective customer, client, vendor, service provider, supplier, contractor or any other person having
business dealings with the Company to cease doing business or otherwise transacting business with the Company or to reduce the amount
of business it conducts or will conduct with the Company; (iii)&nbsp;call on or solicit any suppliers or vendors of the Company in any
manner adverse to the Company&rsquo;s business interests; (iv)&nbsp;accept business from any actual or prospective customer, client, vendor,
service provider, supplier, contractor or any other person having business dealings with the Company; or (v)&nbsp;otherwise disrupt, damage
or interfere in any manner with the relationship between the Company and any of their actual or prospective customers, clients, vendors,
service providers, or suppliers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify"><U>Acknowledgment.</U> Employee hereby acknowledges that the provisions of <U>Sections 12, 13, and 14</U>
are reasonable and necessary to protect the legitimate business interests of the Company and that the non-competition and non-solicitation
provisions of this Agreement contain reasonable limitations as to time and scope of activities to be restrained, and do not impose a greater
restraint than is necessary to protect the trade secrets, confidential information, goodwill and other legitimate business interests of
the Company. Employee further acknowledges that this Agreement is designed to protect the Company&rsquo;s legitimate business interests,
including without limitation the misuse or inappropriate disclosure of the Company&rsquo;s trade secrets and confidential information,
without unreasonably restricting Employee&rsquo;s ability to work elsewhere if Employee&rsquo;s employment relationship or association
with the Company ends, and that there are employment opportunities outside the scope of the restrictions in this Agreement that exist
and remain available to Employee, and that Employee&rsquo;s skill sets are transferable to other industries and businesses not in competition
with the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">16.</TD><TD STYLE="text-align: justify"><U>Blue Pencil Doctrine.</U> To the except permitted by applicable law, if the duration of, the scope
of or any business activity covered by any provision of <U>Sections 12, 13, and 14</U> is in excess of what is determined to be valid
and enforceable under applicable law, such provision will be construed to cover only that duration, scope or activity that is determined
to be valid and enforceable. Employee hereby acknowledges that these sections will be given the construction that renders their provisions
valid and enforceable to the maximum extent, not exceeding their express terms, possible under applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify"><U>No Violation of Rights of Third Parties.</U> Employee agrees that performance of all the terms of this
Agreement and as an employee of the Company does not and will not breach any agreement to keep in confidence proprietary information,
knowledge or data acquired by Employee prior to employment with the Company, and Employee will not disclose to the Company, or induce
the Company to use, any confidential or proprietary information or material belonging to any previous employer. Employee further represents
Employee is not a party to any other agreement that will interfere with Employee&rsquo;s full compliance with this Agreement. Employee
agrees not to enter into any agreement, whether written or oral, in conflict with the provisions of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">18.</TD><TD STYLE="text-align: justify"><U>Survival.</U> This Agreement (a)&nbsp;will survive Employee&rsquo;s employment by the Company, (b)&nbsp;does
not in any way restrict Employee&rsquo;s right or the right of the Company to terminate Employee&rsquo;s employment at any time, for any
reason or for no reason, (c)&nbsp;inures to the benefit of successors and assigns of the Company, and (d)&nbsp;is binding upon Employee&rsquo;s
heirs and legal representatives.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">19.</TD><TD STYLE="text-align: justify"><U>Post-Employment Disclosure.</U> Employee agrees to disclose promptly in writing to the Company all
Inventions,&nbsp;Ideas, and Expressions of Ideas made or conceived by the Employee during the term of employment by the Company and for
one year thereafter, whether or not Employee believes such Inventions,&nbsp;Ideas, and Expressions of Ideas are subject to this Agreement,
to permit a determination by the Company as to whether or not the Inventions,&nbsp;Ideas, and Expressions of Ideas are the property of
the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">20.</TD><TD STYLE="text-align: justify"><U>Injunctive Relief.</U> Employee acknowledges that a breach of any of the promises or agreements contained
herein will result in irreparable and continuing damage to the Company for which there will be no adequate remedy at law, and the Company
shall be entitled to injunctive relief and/or a decree for specific performance, and such other relief as may be proper (including monetary
damages if appropriate).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">21.</TD><TD STYLE="text-align: justify"><U>Notices.</U> Any notice required or permitted by this Agreement must be in writing and must be delivered
as follows with notice deemed given as indicated: (i)&nbsp;by personal delivery when delivered personally; (ii)&nbsp;by overnight courier
upon written verification of receipt; (iii)&nbsp;by telecopy or facsimile transmission upon acknowledgement of receipt of electronic transmission;
or (iv)&nbsp;by certified or registered mail, return receipt requested, upon verification of receipt. Notices to Employee may be sent
to the most recent address of Employee in the Company&rsquo;s records or such other address as Employee may specify in writing. Notices
to the Company will be sent to the Company&rsquo;s Chief Executive Officer at 3701 Wayzata Blvd, Suite&nbsp;300, Minneapolis, MN 55416
USA or to such other address as the Company may specify in writing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">22.</TD><TD STYLE="text-align: justify"><U>Notice to Employee from Company.</U> This Agreement does not apply to an invention for which no equipment,
supplies facility or trade secret information of the employer was used, and which was developed entirely on the employee&rsquo;s own time,
and (1)&nbsp;which does not relate (a)&nbsp;directly to the business of the employer or (b)&nbsp;to the employer&rsquo;s actual or demonstrably
anticipated research or development, or (2)&nbsp;which does not result from any work performed by the employee for the employer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">23.</TD><TD STYLE="text-align: justify"><U>Governing Law.</U> Subject to <U>Exhibit&nbsp;A</U>, this Agreement will be governed in all respects
by the laws of the United States of America and by the laws of the State of Delaware, without regards to the conflict of laws provisions
thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">24.</TD><TD STYLE="text-align: justify"><U>Jurisdiction and Venue</U>. Subject to <U>Exhibit&nbsp;A</U>, Employee and the Company consent to jurisdiction
of the courts of the State of Delaware and/or the federal courts, District of Delaware, for the purpose of resolving all issues of law,
equity, or fact, arising out of or in connection with this Agreement. Any action involving claims of a breach of this Agreement must be
brought in such courts. Each party consents to personal jurisdiction over such party in the state and/or federal courts of Delaware and
hereby waives any defense of lack of personal jurisdiction. Venue, for the purpose of all such suits, will be in New Castle County, State
of Delaware.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">25.</TD><TD STYLE="text-align: justify"><U>Severability.</U> Subject to <U>Section&nbsp;16</U>, to the extent that any portion of any provision
of this Agreement is held invalid or unenforceable, it will be considered deleted herefrom and the remainder of such provision and of
this Agreement will be unaffected and will continue in full force and effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">26.</TD><TD STYLE="text-align: justify"><U>Waiver.</U> The waiver by the Company of a breach of any provision of this Agreement by Employee will
not operate or be construed as a waiver of any other or subsequent breach by Employee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">27.</TD><TD STYLE="text-align: justify"><U>Amendments</U>. No amendment or modification of this Agreement will be deemed effective unless made
in writing and signed by the parties hereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">28.</TD><TD STYLE="text-align: justify"><U>Assignment</U>. This Agreement will not be assignable, in whole or in part, by either party without
the prior written consent of the other party, except that the Company may, without the consent of Employee, assign its rights and obligations
under this Agreement (1)&nbsp;to an Affiliate or (2)&nbsp;to any corporation or other person or business entity to which the Company may
sell or transfer all or substantially all of its assets.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">29.</TD><TD STYLE="text-align: justify"><U>Entire Agreement.</U> This Agreement represents the entire understanding of the parties with respect
to the subject matter of this Agreement and supersedes all previous understandings, written or oral. This Agreement may be amended or
modified only with the written consent of both Employee and the Company. No oral waiver, amendment or modification shall be effective
under any circumstances whatsoever.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">30.</TD><TD STYLE="text-align: justify"><U>Counterparts</U>. This Agreement may be executed by facsimile or electronic signature and in any number
of counterparts, and such counterparts executed and delivered, each as an original, will constitute but one and the same instrument.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">31.</TD><TD STYLE="text-align: justify"><U>Captions and Headings</U>. The captions and section or paragraph headings used in this Agreement are
for convenience of reference only and will not affect the construction or interpretation of this Agreement or any of the provisions hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed and delivered as of the Effective Date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>COMPANY</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%">&nbsp;</TD>
<TD STYLE="width: 3%">&nbsp;</TD>
<TD STYLE="width: 47%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="2"><B>EMPLOYEE</B></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&nbsp;A TO<BR>
CONFIDENTIALITY, ASSIGNMENT OF INTELLECTUAL PROPERTY AND<BR>
RESTRICTIVE COVENANTS AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STATE LAW MODIFICATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The purpose of this <U>Exhibit&nbsp;A</U> to the
Confidentiality, Assignment of Intellectual Property and Restrictive Covenants Agreement (the &ldquo;<B>Agreement</B>&rdquo;) is to modify
certain terms of the Agreement while Employee is providing services to the Company (as defined in the Agreement) in certain states as
described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Agreement remains in effect and applies to
Employee while Employee is employed by the Company or any of its Affiliates. However, if Employee is employed by the Company or any of
its Affiliates in one of the states listed below, the provisions for that state modify the Agreement as indicated, but only while Employee
remains employed by the Company or any of its Affiliates in that state or territory or as otherwise provided by applicable law. If, at
any time, Employee is relocated by the Company or any of its Affiliates to another state, then this Agreement&rsquo;s provisions for the
new location will apply, instead of the provisions for Employee&rsquo;s former location.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If no specific modifications are listed for the
state in which Employee is employed, this <U>Exhibit&nbsp;A</U> does not apply. For purposes of this <U>Exhibit&nbsp;A</U>, Employee is
employed in only one state at any given time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>CALIFORNIA</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in California, <U>Section&nbsp;7</U> (Inventions,&nbsp;Ideas, and Expressions of Ideas) shall not apply to any inventions
that qualify under the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Any provision in an employment agreement
which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall
not apply to an invention that the employee developed entirely on his or her own time without using the employer&rsquo;s equipment, supplies,
facilities, or trade secret information except for those inventions that either: (1)&nbsp;relate at the time of conception or reduction
to practice of the invention to the employer&rsquo;s business, or actual or demonstrably anticipated research or development of the employer;
or (2)&nbsp;result from any work performed by the employee for the employer. To the extent a provision in an employment agreement purports
to require an employee to assign an invention otherwise excluded from being required to be assigned under California Labor Code Section&nbsp;2870(a),
the provision is against the public policy of this state and is unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in California, <U>Section&nbsp;4</U> (Nondisclosure of Proprietary Information) shall not be applied in a manner that
prohibits Employee from disclosing any factual information related to a claim filed in a civil action or a charge filed with a governmental
agency as specifically permitted under Section&nbsp;1001 of the California Code of Civil Procedure, or from discussing or disclosing information
about unlawful acts in the workplace such as harassment or discrimination or any other conduct that Employee has reasonable cause to believe
is unlawful as specifically permitted under Section&nbsp;12964.5 of the California Government Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in California, disregard <U>Section&nbsp;12</U> (Agreement Not to Compete) <FONT STYLE="background-color: white">with
respect to any restriction after Employee&rsquo;s employment with the Company ends for any reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in California, the below replaces <U>Section&nbsp;13</U> (Agreement Not to Solicit or Hire) in its entirety:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-size: 10pt">13.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Agreement
Not to Solicit or Hire.</U> During Employee&rsquo;s employment with the Company or any Affiliates of the Company and for a period of
twelve (12) consecutive months from and after the termination of Employee&rsquo;s employment, whether such termination is with or without
cause, or whether such termination is at the instance of Employee or the Company, Employee will not, except on behalf of the Company,
directly or indirectly, solicit or otherwise directly or indirectly request, advise or induce any then current employee or contractor
of the Company to terminate or otherwise adversely change its relationship with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in California, the below replaces <U>Section&nbsp;14</U> (Agreement Not to Solicit) in its entirety:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-size: 10pt">14.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Agreement
Not to Solicit</U>. During Employee&rsquo;s employment with the Company or any of its Affiliates, Employee will not, except on behalf
of the Company, directly or indirectly, solicit or accept business from any current customer, supplier or other business contact of the
Company. After the termination of Employee&rsquo;s employment, whether such termination is with or without cause, or whether such termination
is at the instance of Employee or the Company, Employee will not, directly or indirectly, individually or as a participant with any other
person or company, or on behalf of myself or any third party: (i)&nbsp;solicit or accept business from any current or potential customer,
supplier or other business contact of the Company, or (ii)&nbsp;interfere with the relationship between the Company or any current or
potential customer, supplier or other business contact of the Company in a manner that is detrimental to, or reasonably likely to be detrimental
to, the legitimate business interests of the Company or any of its Affiliates, in any case if, in so doing, Employee accesses, uses or
discloses any Company Proprietary Information. Employee acknowledges and agrees that the names and addresses of the Company&rsquo;s and
its Affiliates&rsquo; customers, suppliers or other business contacts, and all other confidential information related to them, including
their buying and selling habits and special needs, whether created or obtained by, or disclosed to Employee during Employee&rsquo;s employment,
constitute Company Proprietary Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in California, disregard <U>Section&nbsp;23 </U>(Governing Law) and <U>Section&nbsp;24</U> (Jurisdiction and Venue).
These sections do not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>COLORADO</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company in Colorado,
this Agreement&mdash;including but not limited to Section&nbsp;4 (Nondisclosure of Proprietary Information)&mdash;shall not be applied
in a manner that prohibits Employee from discussing or disclosing, either orally or in writing, information or underlying facts of any
alleged discriminatory or unfair employment practice, or any other conduct as specifically permitted under Colorado Revised States Section&nbsp;34-34-407.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in Colorado, disregard <U>Section&nbsp;23 </U>(Governing Law) and <U>Section&nbsp;24</U> (Jurisdiction and Venue). These
sections do not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>DISTRICT OF COLUMBIA</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in the District of Columbia, disregard <U>Section&nbsp;12</U> (Agreement Not to Compete). This section does not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>ILLINOIS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in Illinois, the below shall replace the second paragraph of this Agreement in its entirety:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">In consideration of employment by the
Company, and as a condition of Employee&rsquo;s initial employment the Company, the compensation and benefits Employee will earn in connection
with such employment, the Company providing Employee with access to Company Proprietary Information (as defined in <U>Section&nbsp;3</U>
below), and other good and valuable consideration, including, a one-time payment in the amount of $500.00, less applicable withholdings,
the sufficiency and receipt of which Employee acknowledges is adequate consideration as required under 820 ILCS 90/15, Employee and Company
agree as follows and as modified in the Exhibits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in Illinois, the following section is added to the Agreement as <U>Section&nbsp;32</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-size: 10pt">32.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notice.</U>
Employee understands and acknowledges that Employee is hereby being advised by the Company to consult with an attorney prior to signing
this Agreement. Employee&rsquo;s decision whether to sign this Agreement is Employee&rsquo;s voluntary decision and made with full knowledge
that the Company has advised Employee to consult with an attorney. Employee understands that Employee has 14 calendar days from the date
Employee receives this Agreement to consider whether Employee wishes to sign this Agreement. If Employee signs this Agreement before the
end of the 14-day period, it will be Employee&rsquo;s voluntary decision to do so because Employee has decided that Employee does not
need any additional time to decide whether to sign this Agreement. Employee also agrees that any changes made to this Agreement before
Employee signs it, whether material or immaterial, will not restart the 14-day period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>LOUISIANA</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If Employee is employed by the Company or any
of its Affiliates in Louisiana, the following shall replace the &ldquo;<B>Restricted Territory</B>&rdquo; definition in <U>Sections 12</U>
(Agreement Not to Compete) and <U>14</U> (Agreement Not to Solicit):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;<B>Restricted Territory</B>&rdquo;
means any municipality or parish in which Employee performed services for the Company during Employee&rsquo;s employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>MASSACHUSETTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If Employee is a resident or employed by the Company
or any of its Affiliates in Massachusetts, the below shall replace the second paragraph of this Agreement in its entirety:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">In consideration of employment by the
Company, and as a condition of Employee&rsquo;s initial employment the Company, the compensation and benefits Employee will earn in connection
with such employment, the Company providing Employee with access to Company Proprietary Information (as defined in <U>Section&nbsp;3</U>
below), and other good and valuable consideration, including, a one-time payment in the amount of $500.00, less applicable withholdings,
the sufficiency and receipt of which Employee acknowledges is independent from initial or continued employment, and that such consideration
is mutually agreed by the parties as required under Mass. Gen. L. ch. 149 &sect; 24L, Employee and Company agree as follows and as modified
in the Exhibits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If Employee is, and for at least 30 days immediately
preceding the termination of Employee&rsquo;s employment with the Company or any of its Affiliates, a resident or employed in Massachusetts,
the following replaces <U>Section&nbsp;23</U> (Governing Law) in its entirety:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">This Agreement will be governed by and
construed in accordance with the laws of the Commonwealth of Massachusetts, without giving effect to its laws pertaining to conflict of
laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If Employee is, and for at least 30 days immediately
preceding the termination of Employee&rsquo;s employment with the Company or any of its Affiliates, a resident or employed in Massachusetts,
the following replaces <U>Section&nbsp;24</U> (Jurisdiction and Venue) in its entirety:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The parties mutually agree that any litigation
regarding the interpretation or enforcement of this Agreement shall be brought in the Business Litigation Section&nbsp;of the Superior
Court of Suffolk County, Massachusetts, and Employee consents to the exercise of personal jurisdiction over Employee by that court. Employee
agrees that the Business Litigation Section&nbsp;of the Superior Court of Suffolk County, Massachusetts shall be the exclusive forum for
litigation regarding the interpretation or enforcement of this Agreement. By so agreeing, Employee understands that Employee is surrendering
the right to commence litigation against the Company outside that court.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>NORTH DAKOTA</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in North Dakota, disregard <U>Section&nbsp;12</U> (Not to Compete) <FONT STYLE="background-color: white">with respect
to any restriction after Employee&rsquo;s employment with the Company ends for any reason. This section does not apply with respect to
any restriction after Employee&rsquo;s employment with the Company ends for any reason</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>OKLAHOMA</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in Oklahoma, disregard <U>Section&nbsp;12</U> (Not to Compete) <FONT STYLE="background-color: white">with respect to
any restriction after Employee&rsquo;s employment with the Company ends for any reason. This section does not apply with respect to any
restriction after </FONT>Employee&rsquo;s <FONT STYLE="background-color: white">employment with the Company ends for any reason</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>OREGON</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in Oregon, the following section is added to the Agreement as <U>Section&nbsp;32</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-size: 10pt">32.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notice.</U>
Employee understands and acknowledges that Employee is hereby being advised by the Company to consult with an attorney prior to signing
this Agreement. Employee&rsquo;s decision whether to sign this Agreement is Employee&rsquo;s voluntary decision and made with full knowledge
that the Company has advised Employee to consult with an attorney. Employee understands that Employee has 14 calendar days from the date
Employee receives this Agreement to consider whether Employee wishes to sign this Agreement. If Employee signs this Agreement before the
end of the 14-day period, it will be Employee&rsquo;s voluntary decision to do so because Employee has decided that Employee does not
need any additional time to decide whether to sign this Agreement. Employee also agrees that any changes made to this Agreement before
Employee signs it, whether material or immaterial, will not restart the 14-day period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>WASHINGTON</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Employee is employed by the Company or any
of its Affiliates in Washington, disregard <U>Section&nbsp;23 </U>(Governing Law) and <U>Section&nbsp;24</U> (Jurisdiction and Venue).
These sections do not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>WISCONSIN</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If Employee is employed by the Company or any
of its Affiliates in Wisconsin, the following shall be added to the end of <U>Section&nbsp;13</U> (Agreement Not to Solicit or Hire):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">This covenant applies only to employees,
officers, or consultants of the Company or its Affiliates with whom the Employee had Material Contact during the last two years of the
Employee&rsquo;s employment with the Company or its affiliates. For the purposes of this <U>Section&nbsp;13</U>, &ldquo;<B>Material Contact</B>&rdquo;
means direct personal contact between the Employee and such employee, officer, or consultant of the Company or its Affiliates in the course
of the performance of the Employee&rsquo;s job duties on behalf of the Company or its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If Employee is employed by the Company or any
of its Affiliates in Wisconsin, the below shall replace <U>Section&nbsp;14</U> (Agreement Not to Solicit) in the entirety:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-size: 10pt">14.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Agreement
Not to Solicit.</U> During Employee&rsquo;s employment with the Company or any Affiliates of the Company and for a period of twelve (12)
consecutive months from and after the termination of Employee&rsquo;s employment, whether such termination is with or without cause, or
whether such termination is at the instance of Employee or the Company, Employee will not, except on behalf of the Company, solicit or
accept business from any current or potential customer, supplier or other business contact of the Company of which Employee serviced,
solicited, or contacted in any way during Employee&rsquo;s employment with the Company or any Affiliates of the Company or about whom
Employee had trade secret or Company Proprietary Information of, or interfere with the relationship between the Company or any of its
Affiliates and any current or potential customer, supplier or other business contact of the Company in a manner that is detrimental to,
or reasonably likely to be detrimental to, the legitimate business interests of the Company or any of its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&nbsp;B TO<BR>
CONFIDENTIALITY, ASSIGNMENT OF INTELLECTUAL PROPERTY AND<BR>
RESTRICTIVE COVENANTS AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><B>LIST OF PRIOR INVENTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Title</U></FONT></TD>
    <TD STYLE="width: 25%; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Date</U></FONT></TD>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Identifying Number or Brief Description</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="border-bottom: Black 1pt solid; width: 5%"></TD>
    <TD STYLE="width: 45%"><B>No inventions or improvements &nbsp;</B></TD>
<TD STYLE="width: 50%"></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="2">Signature of Employee:</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="2">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="2">Print Name of Employee: </TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>Date:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>4
<FILENAME>tm2412326d1_ex10-4.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;10.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April&nbsp;23, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Daniel Reuvers (By E-mail)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Dan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Thank you again for your thoughtful approach to your retirement from
Tactile Systems Technology,&nbsp;Inc. (the &ldquo;Company&rdquo;). On behalf of the Company&rsquo;s entire Board of Directors (the &ldquo;Board&rdquo;),&nbsp;I
extend the Board&rsquo;s sincere appreciation for your years of dedicated service to the Company and for working with the Board to develop
a smooth transition for you and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The purpose of this letter agreement (&ldquo;Agreement&rdquo;) is to
formalize the terms of your retirement from the Company as its Chief Executive Officer effective as of June&nbsp;30, 2024 (your &ldquo;Retirement
Date&rdquo;) and to confirm the terms of your continued employment and Board service with the Company after your Retirement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CONTINUED SERVICE AS THE COMPANY&rsquo;S CHIEF EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You hereby confirm that you will continue to serve as the Company&rsquo;s
Chief Executive Officer, reporting to the Board, through your Retirement Date, subject to all of the same terms and conditions of your
current at-will employment with the Company. This means that you will continue to receive your current base salary and remain eligible
for all of the same employee benefits through your Retirement Date. You acknowledge and agree that as a result of your voluntary retirement,
you will not be eligible to earn or receive any payment under the Company&rsquo;s annual executive bonus plan or any other form of cash
incentive compensation for 2024. You also will continue to be a participant under the Company&rsquo;s Executive Employee Severance Plan
through your Retirement Date. You further acknowledge and agree that your voluntary retirement from the Company does not make you eligible
to receive any payments or benefits under the Company&rsquo;s Executive Employee Severance Plan or under any other Company severance plan
or program, and that you will cease to be a participant under the Company&rsquo;s Executive Employee Severance Plan effective as of your
Retirement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You acknowledge and agree that you remain bound by the
Confidentiality, Assignment of Intellectual Property and Restrictive Covenants Agreement entered into by and between you and the
Company and effective as of June 8, 2020 (the &ldquo;Restrictive Covenants Agreement&rdquo;), a copy of which has been provided to
you, and nothing in this Agreement is intended to alter the Restrictive Covenants Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>EMPLOYMENT FOLLOWING YOUR RETIREMENT DATE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subject to you remaining employed by the Company through your Retirement
Date, commencing as of 12:01 a.m.&nbsp;following your Retirement Date, you will continue to be employed by the Company as Advisor to the
Chief Executive Officer through March&nbsp;31, 2025, unless prior to such date the Company terminates your employment for Cause (as defined
below) or you resign for any reason. In this role, you will be an exempt employee reporting to the Board, and your duties will be limited
to providing operational support to the Company&rsquo;s Chief Executive Officer, assisting with the implementation of the Company&rsquo;s
2024 operating plan and otherwise assisting in the transition of your duties and responsibilities to the Company&rsquo;s next Chief Executive
Officer. You would not be restricted from any non-competitive activity, so long as it doesn&rsquo;t restrict your ability to fulfill your
duties as Advisor to the Chief Executive Officer. In this role you will be paid an annualized salary of $525,000, subject to applicable
withholdings. You will not be eligible to earn or receive any form of cash incentive compensation for 2024 or any subsequent year. You
also will not be eligible to receive any additional equity grants for 2024 or any subsequent year. Your eligibility for any employee benefits
will be determined in accordance with the applicable Company-sponsored benefit plans and policies. If you become ineligible for active
employee group medical, dental or vision coverage during your employment with the Company after your Retirement Date, then, subject to
you taking all steps necessary to continue your group medical, dental or vision coverage pursuant to COBRA, the Company will pay the portion
of the premium costs for such coverage that the Company would pay if you had remained eligible for active employee coverage for the period
commencing as of the first date on which you are no longer eligible for active employee group medical, dental or vision coverage and continuing
through the earlier of December&nbsp;31, 2025 or the date on which you are no longer eligible to continue COBRA-related group medical,
dental or vision coverage (as applicable) under applicable law. If you remain employed by the Company as of March&nbsp;31, 2025, then
any continued employment will be subject to the terms and conditions of employment, including with respect to compensation and responsibilities,
mutually agreed to by you and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<IMG SRC="tm2412326d1_ex10-4img002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For purposes of this Agreement, &ldquo;Cause&rdquo; means (i)&nbsp;an
act or acts of dishonesty undertaken by you and intended to result in your personal gain or enrichment or the personal gain or enrichment
of others at the expense of the Company; (ii)&nbsp;unlawful conduct or gross misconduct by you that, in either event, is materially injurious
to the Company; (iii)&nbsp;you being charged with or convicted of a felony; or (iv)&nbsp;any material breach by you of any terms or conditions
of this Agreement, the Restrictive Covenants Agreement or any other written agreement between you and the Company which breach has not
been cured by you within fifteen (15) days after written notice thereof to you from the Company; provided, however, that for the purposes
of clauses (ii)&nbsp;and (iv)&nbsp;above, no act or failure to act on your part shall be considered &ldquo;Cause&rdquo; if done by you
pursuant to specific authorization evidenced by a resolution duly adopted by the Board or pursuant to specific advice given by counsel
for the Company, unless such specific authorization or advice results in whole or in part from material misrepresentations or omissions
by you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CONTINUED BOARD SERVICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Agreement does not affect your current Board service. You will
not receive any compensation for your Board service through March&nbsp;31, 2025 or any subsequent period you remain employed by the Company.
If your employment with the Company ends effective March&nbsp;31, 2025, and you continue to serve on the Board following the Company&rsquo;s
2025 annual meeting of stockholders, then you will be eligible to receive standard non-employee director fees in accordance with the Board&rsquo;s
typical practices for non-employee directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>YOUR EQUITY RIGHTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You acknowledge and agree that you have reviewed a list of all performance
share unit awards and restricted stock unit awards received by you during your employment with the Company (the &ldquo;Equity Awards&rdquo;),
and that you have no other equity or equity-based compensation rights with respect to the Company or any affiliate. The Equity Awards
shall continue to be governed by the terms and conditions set forth in the applicable written performance share unit agreements and restricted
stock unit agreements. The Company agrees that the plans and agreements for the Equity Awards provide for continued vesting of the Equity
Awards through the end of your employment or other service with the Company as long as you continue providing services to the Company
as provided under the Equity Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<IMG SRC="tm2412326d1_ex10-4img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2412326d1_ex10-4img002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You further acknowledge and agree that you have no right to receive
any new performance share unit awards, restricted stock unit awards, or other equity-related awards in connection with your employment
or Board service after the date of this Agreement, unless your Board service is extended beyond May&nbsp;2025, in which case you&rsquo;d
be eligible to receive standard non-employee director fees and/or equity grants in accordance with the Board&rsquo;s typical practices
for non-employee directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement contains the complete, entire understanding between you and the Company regarding the subject matter of this Agreement and supersedes
all prior and contemporaneous oral and written agreements and discussions with respect to the subject matter hereof; provided, however,
that nothing in this Agreement supersedes or replaces any of the terms of any Company policy or the terms of the Restrictive Covenants
Agreement (a copy of which is enclosed with this Agreement) or any </FONT>plans and agreements for the Equity Awards, each of which remains
in effect in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ACCEPTANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Please sign and return this countersigned Agreement
to me no later than April&nbsp;23, 2024 to confirm your agreement to all terms included in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ William W. Burke</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Elaine Birkemeyer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William W. Burke</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elaine Birkemeyer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair, Board of Directors</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acknowledged and Agreed To:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Daniel Reuvers </FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel Reuvers</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April&nbsp;23, 2024</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2412326d1_ex10-4img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>tm2412326d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tactile Medical Announces CEO Transition and
Preliminary First Quarter 2024 Revenue</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">CEO Dan Reuvers to retire; Healthcare veteran and board director Sheri Dodd
appointed as Chief Executive Officer</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Preliminary, unaudited total revenue for first quarter
of 2024 expected to be approximately $61 million </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Management to host conference call on May 6, 2024
to discuss first quarter 2024 financial results </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">MINNEAPOLIS, MN, April 23, 2024 &ndash; Tactile
Systems Technology, Inc. (&ldquo;Tactile Medical&rdquo;; the &ldquo;Company&rdquo;) (Nasdaq: TCMD), a medical technology company providing
therapies for people with chronic disorders, today announced that Dan Reuvers will retire as the Company&rsquo;s Chief Executive Officer,
effective June 30, 2024. Concurrently, the Company announced the appointment of Sheri Dodd, a member of the Company&rsquo;s board of directors,
as Chief Executive Officer, effective July 1, 2024. Following such date, Mr. Reuvers will serve as an advisor to Ms. Dodd through March
31, 2025 in support of the transition, as well as remain a member of the Company's board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Sheri brings the ideal blend of experience leading businesses
within the chronic care space, expertise in health economics &amp; reimbursement, and a deep familiarity with Tactile Medical through
her service as a member of our board of directors. Prior to her most recent role as President of Medtronic Canada, Sheri led Medtronic&rsquo;s
Care Management Services business, focused on caring for complex patients in the home, as well as leading Medtronic&rsquo;s non-intensive
diabetes therapy business. In addition to general management positions, Sheri also led global clinical research, health economics, reimbursement
and policy for Medtronic across multiple cardiac and vascular businesses. Sheri&rsquo;s leadership roles at both Johnson &amp; Johnson
and the World Health Organization contributed to her understanding of the complex payer climate. Sheri has been a thoughtful and respected
voice on our board, and I am confident Tactile will benefit from her leadership as our new CEO,&rdquo; said William W. Burke, Chairman
of the board of Tactile Medical.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Burke added, &ldquo;We are grateful to Dan for his impact over
the past four years. Under his leadership, our portfolio has been revitalized, a world-class leadership team has been assembled, and revenue
and profitability have grown, all while serving thousands of new patients. Tactile&rsquo;s strong balance sheet is poised to support continued
growth. We are pleased that Tactile will continue to benefit from Dan&rsquo;s involvement as an advisor to Sheri and as a member of our
board of directors.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Following several years as an independent director for Tactile,
I am excited to take a leading role for the Company as Chief Executive Officer,&rdquo; said Sheri Dodd. &ldquo;I look forward to working
closely with the entire leadership team as we focus on furthering our mission of revealing and treating patients with underserved chronic
conditions while delivering sustainable, profitable growth.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&quot;I am proud of the significant progress we have made over the
past several years at Tactile Medical,&rdquo; said Dan Reuvers. &ldquo;I look forward to working with Sheri and the board of directors
to build upon the foundation we&rsquo;ve established and create additional shareholder value.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Preliminary, Unaudited First Quarter 2024 Revenue</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>The Company
also announced preliminary unaudited first quarter 2024 total revenue. Total revenue for the first quarter of 2024 is expected to be
approximately $61 million, compared to $58.8 million in the first quarter of 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preliminary, unaudited revenue results described in this press
release are estimates only and are subject to change in connection with the completion of the Company&rsquo;s financial closing process
and the preparation of its full financial statements for the quarter ended March 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Conference Call</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management will host a conference call with a question and answer session
at 5:00 p.m. Eastern Time on May 6, 2024 to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088
(201-389-0927 for international callers) and provide access code 13745955. A live webcast of the call will also be provided on the investor
relations section of the Company's website at investors.tactilemedical.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For those unable to participate, a replay of the call will be available
for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13745955. The webcast will be archived at investors.tactilemedical.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Sheri Dodd </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Sheri Dodd brings nearly 30 years of experience
across the global pharmaceutical, medical device, and digital health industries to her new role as CEO of Tactile Medical. She joins
Tactile Medical following 14 years at Medtronic plc. where she held roles of increasing responsibility, most recently as President
of Medtronic Canada with responsibility for all commercial activities related to the sale and distribution of the Medtronic
portfolio in Canada. Earlier in her career at Medtronic, Ms. Dodd served in various functional vice president positions including
healthcare economics &amp; market access, clinical research, health economics &amp; policy, and general management positions for
non-intensive diabetes therapies and telehealth. Prior to joining Medtronic, she also <FONT STYLE="background-color: white">held
various positions with Johnson &amp; Johnson, most recently as Vice President of Health Economics and Reimbursement for Ethicon,
Inc.</FONT> Ms. Dodd holds a Bachelor of Science from the College of Idaho and a Masters of Science in Health Planning and Financing
from the London School of Economics and London School of Hygiene and Tropical Medicine. In addition, Ms. Dodd has served as a member
of Tactile Medical&rsquo;s board of directors since 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Tactile Systems Technology, Inc. (DBA Tactile Medical)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal; font-weight: normal">Tactile
Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including
lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves
at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall
healthcare costs and improve the quality of life for tens of thousands of patients each year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Legal Notice Regarding Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">This release contains forward-looking statements.
Forward-looking statements are generally identifiable by the use of words like &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo;
 &ldquo;could,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;believe,&rdquo; &ldquo;intend,&rdquo;
 &ldquo;continue,&rdquo; &ldquo;confident,&rdquo; &ldquo;outlook,&rdquo; &ldquo;guidance,&rdquo; &ldquo;project,&rdquo; &ldquo;goals,&rdquo;
 &ldquo;look forward,&rdquo; &ldquo;poised,&rdquo; &ldquo;designed,&rdquo; &ldquo;plan,&rdquo; &ldquo;return,&rdquo; &ldquo;focused,&rdquo;
 &ldquo;prospects&rdquo; or &ldquo;remain&rdquo; or the negative of these words or other variations on these words or comparable terminology.
The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors
and uncertainties outside of the Company&rsquo;s control that can make such statements untrue, including, but not limited to, the impacts
of inflation, rising interest rates or a recession; the adequacy of the Company&rsquo;s liquidity to pursue its business objectives; the
Company&rsquo;s ability to obtain reimbursement from third-party payers for its products; adverse economic conditions or intense competition;
price increases for supplies and components; wage and component price inflation; loss of a key supplier; entry of new competitors and
products; compliance with and changes in federal, state and local government regulation; loss or retirement of key executives, including
prior to identifying a successor; technological obsolescence of the Company&rsquo;s products; technical problems with the Company&rsquo;s
research and products; the Company&rsquo;s ability to expand its business through strategic acquisitions; the Company&rsquo;s ability
to integrate acquisitions and related businesses; the effects of current and future U.S. and foreign trade policy and tariff actions;
or the inability to carry out research, development and commercialization plans. In addition, other factors that could cause actual results
to differ materially are discussed in the Company&rsquo;s filings with the SEC. Investors and security holders are urged to read these
documents free of charge on the SEC&rsquo;s website at http://www.sec.gov. The Company undertakes no obligation to publicly update or
revise its forward-looking statements as a result of new information, future events or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Investor Inquiries:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Sam Bentzinger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Gilmartin Group</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">investorrelations@tactilemedical.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>tcmd-20240423.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWauHmbOdzZR+mYkxtmB3bYkKryQsXT2+3SCV7nSm0d0J -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:TCMD="http://tactilemedical.com/20240423" elementFormDefault="qualified" targetNamespace="http://tactilemedical.com/20240423">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://tactilemedical.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="tcmd-20240423_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="tcmd-20240423_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>tcmd-20240423_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>tcmd-20240423_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://tactilemedical.com/role/Cover" xlink:href="tcmd-20240423.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://tactilemedical.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2412326d1_ex10-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2412326d1_ex10-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  E U(# 2(  A$! Q$!_\0
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M \#YEZ?Y_BI<_P"TO^?^!5]7_P 0VX/_ .A54_\ !U8^&_XBEQS_ -###?\
MA+2_^1/[;/\ B+3\"_\ 1GWBK_POK#_YG*/^(M/P+_T9]XJ_\+ZP_P#F<K^)
M//\ M+_G_@5&?]I?\_\  J7_ !#7A'_H4U/_  ;6#_B*7'/_ $,,-_X2TO\
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M@?L?^*C[CQ]8<_\ ENTG_$6GX%_Z,^\5?^%]8?\ S.5_$GG_ &E_S_P*C/\
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M>8;A>7]P."C9SC3G(P5.#LZ$XS7D'3Y=J_-C@@*2.."4S@=B0 ".*]FAX>Y
MH)U<IJ)O6*]K-+6/O.R:\M-%^"/SK.?&SC".)E1RG,Z$H8=2I5VZ%)VK<SG'
M5Q?_ "[^;W>EF?T=?\/TO#?_ $0C6BN >/$UACCV^P'@X)]^@Z4#_@NCX; _
MY()K'K@>)['\O^/#MTR3]37\X@&!U<MQQE <#//)QM'<<]"<8)W.!!'WB01Z
MQ\Y[G'<]>,=>E=4/#WAIWOE=1ZK_ )>U=K/L^NY\_3\;O$A\U\SP_P 2?\"C
MI[JMO&*VVY6UKK:Y_1U_P_2\-_\ 1!-8_P#"GL?_ )7T?\/TO#?_ $036/\
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M_H@FL?\ A3V7_P KZ/\ A^EX;_Z()K'_ (4]E_\ *^OYQL^Y_-*,^Y_-*/\
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MO#7_ $*ZW_@VM_F'_$;/$?\ Z&6&_P#!%'_(_HY_X?I>&_\ H@FL?^%/9?\
MROH_X?I>&_\ H@FL?^%/9?\ ROK^<;/N?S2C/N?S2C_B'O#7_0KK?^#:W^8?
M\1L\1_\ H98;_P $4?\ (_HY_P"'Z7AO_H@FL?\ A3V7_P KZ/\ A^EX;_Z(
M)K'_ (4]E_\ *^OYQL^Y_-*,^Y_-*/\ B'O#7_0KK?\ @VM_F'_$;/$?_H98
M;_P11_R/Z.?^'Z7AO_H@FL?^%/9?_*^C_A^EX;_Z()K'_A3V7_ROK^<;/N?S
M2C/N?S2C_B'O#7_0KK?^#:W^8?\ $;/$?_H98;_P11_R/Z.?^'Z7AO\ Z()K
M'_A3V7_ROH_X?I>&_P#H@FL?^%/9?_*^OYQL^Y_-*,^Y_-*/^(>\-?\ 0KK?
M^#:W^8?\1L\1_P#H98;_ ,$4?\C^CG_A^EX;_P"B":Q_X4]E_P#*^C_A^EX;
M_P"B":Q_X4]E_P#*^OYQL^Y_-*,^Y_-*/^(>\-?]"NM_X-K?YA_Q&SQ'_P"A
MEAO_  11_P C^CG_ (?I>&_^B":Q_P"%/9?_ "OH_P"'Z7AO_H@FL?\ A3V7
M_P KZ_G&S[G\THS[G\TH_P"(>\-?]"NM_P"#:W^8?\1L\1_^AEAO_!%'_(_H
MY_X?I>&_^B":Q_X4]E_\KZ/^'Z7AO_H@FL?^%/9?_*^OYQL^Y_-*,^Y_-*/^
M(>\-?]"NM_X-K?YA_P 1L\1_^AEAO_!%'_(_HY_X?I>&_P#H@FL?^%/9?_*^
MC_A^EX;_ .B":Q_X4]E_\KZ_G&S[G\THS[G\TH_XA[PU_P!"NM_X-K?YA_Q&
MSQ'_ .AEAO\ P11_R/Z.?^'Z7AO_ *()K'_A3V7_ ,KZ/^'Z7AO_ *()K'_A
M3V7_ ,KZ_G&S[G\THS[G\TH_XA[PU_T*ZW_@VM_F'_$;/$?_ *&6&_\ !%'_
M "/Z.?\ A^EX;_Z()K'_ (4]E_\ *^C_ (?I>&_^B":Q_P"%/9?_ "OK^<;/
MN?S2C/N?S2C_ (A[PU_T*ZW_ (-K?YA_Q&SQ'_Z&6&_\$4?\C^CG_A^EX;_Z
M()K'_A3V7_ROH_X?I>&_^B":Q_X4]E_\KZ_G&S[G\THS[G\TH_XA[PU_T*ZW
M_@VM_F'_ !&SQ'_Z&6&_\$4?\C^C3_A^AX7;(D^ NM/&2K;!XIL@ 2^-RM_9
M_!Z=,Y /;!'7_#/_ (+0>&_B'\4/AK\-X/@7K6D-\1?B'X)\ P:S+XALKFVT
MEO&>NVGARWU0Q_8 TJ6MW=$.@VF0H8]PR"/YFB#D'.=Q)Y*[AM*EB,\8PNT[
M<@\J,R'*>V_LQD#]J3]EP9.&_:4_9Y9@2?NK\7_#; #DEE.\Y.6.!P^6);@S
M/@CAC!X3,<7AHU(U,-E[J>R=2I[E:%*3Y'JK\E1.&MUMS75T>KD/C)X@YGQ!
MD.4RS+#_ %#&YA1H8^?L*2DG4KTX5HJ44FDG)V47>5]TD[_W<?9[I?E\B.7;
MQYKO KR8X\QE%MA6?[S < D@45>=CO?]XP^9N!NP.3[T5_/CC@[N].-[N^L]
M[N_3O<_M7FG_ -!R7E[G_P B?R(?\'<7'P$_8H]_CAX^'Y?#]C7\.@.7/M@?
M^C*_N*_X.XR%^ G[%!) S\</'HYX_P":?N1U]?Y9K^',.N]OF7@\\CL9,YY[
M'@^F,5_2/AO_ ,DU5_Z^UO\ T](_ECQ=7_&79CI_S"X:WW:V_P O,FHIN]/[
MZ_\ ?0_QHWI_>7_OH?XU^AK9>B_)'YFT[O1[OH^[\AU%-WI_>7_OH?XT;T_O
M+_WT/\:!6?9_<_\ (=13=Z?WE_[Z'^-&]/[R_P#?0_QH"S[/[G_D.HIN]/[R
M_P#?0_QHWI_>7_OH?XT!9]G]S_R'44W>G]Y?^^A_C1O3^\O_ 'T/\: L^S^Y
M_P"0ZBF[T_O+_P!]#_&C>G]Y?^^A_C0%GV?W/_(=13=Z?WE_[Z'^-&]/[R_]
M]#_&@+/L_N?^0ZBF[T_O+_WT/\:-Z?WE_P"^A_C0%GV?W/\ R'44W>G]Y?\
MOH?XT;T_O+_WT/\ &@+/L_N?^0ZBF[T_O+_WT/\ &C>G]Y?^^A_C0%GV?W/_
M "'44W>G]Y?^^A_C1O3^\O\ WT/\: L^S^Y_Y#J*;O3^\O\ WT/\:-Z?WE_[
MZ'^- 6?9_<_\AU%-WI_>7_OH?XT;T_O+_P!]#_&@+/L_N?\ D.HIN]/[R_\
M?0_QHWI_>7_OH?XT!9]G]S_R'44W>G]Y?^^A_C1O3^\O_?0_QH"S[/[G_D.H
MIN]/[R_]]#_&C>G]Y?\ OH?XT!9]G]S_ ,@;M_O#\.O/_P"O(]J_4/\ X),M
M_P 9"^)QRV/A??\ '''_ !,4]3V/X>N.WY=EUX^8=><,,XP2?7'\_2OT\_X)
M/7$-O^T%XKN)9HHX8OA=?RRS2R+&D,*7UHTDFXD99 69$!RY)4?>Q7'F=2^
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MUW7WH=13=Z?WE_[Z'^-&]/[R_P#?0_QH"Z[K[T.HIN]/[R_]]#_&C>G]Y?\
MOH?XT!==U]Z'44W>G]Y?^^A_C1O3^\O_ 'T/\: NNZ^]#J*;O3^\O_?0_P :
M-Z?WE_[Z'^- 77=?>AU%-WI_>7_OH?XT;T_O+_WT/\: NNZ^]#J*;O3^\O\
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M .$>%_\ E ?\.G?^"<?_ $9]\$O_  C-+_\ C%'_  Z=_P""<?\ T9]\$O\
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M?V-DO_0DR7_PT99_\Q!_PPG^R!_T;[\./_!#;?\ Q-'_  PG^R!_T;[\./\
MP0VW_P 3111]?S#_ *&&8?\ A=B__EX?V-DO_0DR7_PT99_\Q!_PPG^R!_T;
M[\./_!#;?_$T?\,)_L@?]&^_#C_P0VW_ ,3111]?S#_H89A_X78O_P"7A_8V
M2_\ 0DR7_P -&6?_ #$'_#"?[('_ $;[\./_  0VW_Q-'_#"?[('_1OOPX_\
M$-M_\3111]?S#_H89A_X78O_ .7A_8V2_P#0DR7_ ,-&6?\ S$'_  PG^R!_
MT;[\./\ P0VW_P 31_PPG^R!_P!&^_#C_P $-M_\3111]?S#_H89A_X78O\
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ML@?]&^_#C_P0VW_Q-'_#"?[('_1OOPX_\$-M_P#$T44?7\P_Z&&8?^%V+_\
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M_$T?\,)_L@?]&^_#C_P0VW_Q-%%'U_,/^AAF'_A=B_\ Y>']C9+_ -"3)?\
MPT99_P#,0P_L)?L@$8_X9^^' R2/^0#;=L_[/<C)[^]7]!_8G_95\/\ B#2/
M$6A? [P%I6O>'-;TO7M$U:UT6V2[TS6-(FM[[3-1LG"C[+>6-Y!!=6MQ!Y<L
M%S$DT;JX))16,L;CI*:ECL;-25I1GC,3.,E=JTXRK2C*-M+237D1/*<HIUZ$
MJ>3Y13E!QJ0E#*LNA*%3FB_:0E'"1E":<5:<7&2MI(^KC'.QSYT0SS@V^2,\
@X)\[GZ]Z***X>6/\D/\ P"'_ ,B?1N$;O3J^K[^I_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm2412326d1_ex10-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2412326d1_ex10-1img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ; O\# 2(  A$! Q$!_\0
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MD?V#>1.UKK<9M[A7T^6ZA>&96*-^,WQHU7POX?\ @9^TUH]C<?!?3=)\/?\
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MHFJZ<4+_ &V J)S;;A("/M 8*;?(S^_W=(A^\8?,JE>:_%O0?C9\/M0^*_\
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MLH-7T^>\1I(WLXKN&2[CDB8K)');*YFC>,JP='167:VX#:V/S7@^ 7P*N?\
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M#^+G[9?PN^,\(+-;>"?B1HOQ-\7:)\(?B[AUG2/3_&%M+;_!;X@7(@-R;_\
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M'\U8V9D61H]N]4=U*HQ4*[#"DG%?R;S>*M8U7]A?QC^QK9_;W?XD_L^>(_\
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M#:K4J:Q"C&"3A*,H2E&<6_V":Y@& 9 "V0H(8$D'!&",Y!QD=1E3C# EBW<
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M67*@D?C3^S]>> OAK^W9>?#;1_#7P.^-7BSXT:5^TU\<=0_:*^%P5/B=\+=
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M$GA:[\/^)[/PCXJU&.Y\-:JMKJTOFZIX;\5Z =;\0Z();Z^^.=2OKE?V2?\
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MJ/A_P;?:YIECXGUC3A\//ANUO=Z?H37,6I7MH1I]_B2VMVAF:RNC@ND]/_;
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M^'%S\.K#]E#4?VB+&+X_ZG\+;[3H_!*21^ ]4N?#=AXLO?"K-9V>@:IXPC\
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M.C:A!#+%<10WVF:E!=65Y%'/##,D=Q!(BRQ1N%W(I'&2_!KX32>%6\!/\,_
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7IQ3C&+Y:<(-QBVXQ;A&%XQ;;2?5L_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm2412326d1_ex10-4img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2412326d1_ex10-4img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  3 OP# 2(  A$! Q$!_\0
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M\>^%?#WVN[D 2VMO-G<;49:^*/A!^Q#XJ^&/QY_9M\1QP:./AM\/_@-I]_\
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M]!67_!0+X;:C\+O#WQ'L? _Q(O-0\1_M23?L@P?#NWTK0)/'%C\7[+XGZO\
M#/6(=1LU\3-I4'A[0%T/5?'FKZNNK.8/A]83:^MJSDV44FK?MX:/H%A\2?&6
MJ_!'XP1_![X1_$GQ-\,_'_QEM!\,M0\,>';WP=XFB\*>*?%5[X7MOB6?B4W@
M?P_?RR7FLZ[:>#+F72]&LM0UJ_T^VTNPOKRUY70_V6?%NF_MSZ]\5TM='B^
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MGQNUWX/T[7?$EW96TUM%%-HNAOJVE>'X-:M+N\2_UVR\4:?<+;7>B3"3X_\
MB9\'OBAXJ_:H\(^.O /P<LOA;<:/\1? VJ>-?VC]"^+YTT?$[X1^'=%676O
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MU\.O$\=CKFHZ!X=TKQ%%'J6N:;=W^_4=2%SX]KWP2_:ITWX4?'#]C?PY\._
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MU>'_ (0Z%X?\TP37VE1_#WX!V]UJ+V\9MH_%E]K-XWDR:J\D_F_@[]@[XU^
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MP4N7&+"5Y89N$*B>)CA:\J$7&;4;3Q#H1;ULM7[JDQGP1^,%S\:/ .E?$-?
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M-3_VT5ON+^'\JCHHH>[]7^;"+?+'5_"OR05(G.<\XQC/..M%%2TK/1;/HO\
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B_/8>M3 #+<#KZ>PHHK./Q6Z).R[;;'2M4KZZ+?7IYW/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm2412326d1_ex10-4img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2412326d1_ex10-4img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  F U(# 2(  A$! Q$!_\0
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M5?Q4;#Z+^;?XT;#Z+^;?XU[/_$.N$O\ H5U?_#EC/_DCPO\ B*G&O_0QPO\
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M?^'3TW_YFZ/^(N#0O^C+/$'_ (=/3?\ YFZ_BGV'T7\V_P :-A]%_-O\:/\
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M(N#0O^C+/$'_ (=/3?\ YFZ_BGV'T7\V_P :-A]%_-O\:/\ B'/"7_0LK?\
MARQ?_P D'_$5.-?^AAA/_#=0_P S^UC_ (BX-"_Z,L\0?^'3TW_YFZ/^(N#0
MN/\ C"OQ![_\74TW]/\ BFJ_BGV'T7\V_P :-A]%_-O\:/\ B'/"7_0LK?\
MARQ?_P D/_B*O&O_ $'X3_PWT?\ ,_M9/_!W!H74_L5^(3G_ *JKIF>AQU\-
M'&3CD]!QSD8^O?V3/^#C'2_VJM7\;Z58?LN:GX3_ .$+TW1M1DGO/B+97XOA
MJLES&(T6+0(?*:&2V?(R=PQG(YK_ #Z,8ZX7ME=Q(R0,X/'&0?7'3U/[)?\
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MW)3_ (?OZ7_T;KJO_A;VO_RLK^=,X ^Z3SSE2!UXQSP!V  & .@/";5_N?\
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M[G>7W1_S%[6C_P _(?\ @4O_ )$7S'_N#\__ *]'F/\ W!^?_P!>DV1>J_\
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M%\Q_[@_/_P"O1YC_ -P?G_\ 7I-D7JO_ '\_^M1LB]5_[^?_ %J/<[R^Z/\
MF'M:/_/R'_@4O_D1?,?^X/S_ /KT>8_]P?G_ /7I-D7JO_?S_P"M1LB]5_[^
M?_6H]SO+[H_YA[6C_P _(?\ @4O_ )$7S'_N#\__ *]'F/\ W!^?_P!>DV1>
MJ_\ ?S_ZU&R+U7_OY_\ 6H]SO+[H_P"8>UH_\_(?^!2_^1%\Q_[@_/\ ^O1Y
MC_W!^?\ ]>DV1>J_]_/_ *U&R+U7_OY_]:CW.\ONC_F'M:/_ #\A_P"!2_\
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MA_P3"_Z,J^!G_A)VO_Q-'_#G#_@F%_T95\#/_"3M?_B:**/[5S3_ *&>8_\
MA;B?_EH?V;EO_0LR[_PAPW_RH/\ ASA_P3"_Z,J^!G_A)VO_ ,31_P .</\
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M\71_P[S_ &,O^C=OAI_X)1_\7111_:69?]#''_\ A9B/_E@?ZN\/?]"#)?\
MPU8'_P"9P_X=Y_L9?]&[?#3_ ,$H_P#BZ/\ AWG^QE_T;M\-/_!*/_BZ**/[
M2S+_ *&./_\ "S$?_+ _U=X>_P"A!DO_ (:L#_\ ,X?\.\_V,O\ HW;X:?\
M@E'_ ,71_P .\_V,O^C=OAI_X)1_\7111_:69?\ 0QQ__A9B/_E@?ZN\/?\
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MC=OAI_X)1_\ %T?\.\_V,O\ HW;X:?\ @E'_ ,7111_:69?]#''_ /A9B/\
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<GD\#J>?2BBBL&E=Z+=]%W9] EHM7LNOEZ'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140238507453968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 23, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 23,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TACTILE SYSTEMS TECHNOLOGY INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001027838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1801204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3701
Wayzata Blvd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minneapolis<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">355-5100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, Par Value $0.001 Per Share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TCMD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M<F]P<R]A<' N>&UL4$L! A0#%     @ ]X&76)A5H^[N    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ ]X&7
M6)E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " #W@9=8@M8>2FX$   L$0  &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ ]X&7
M6)^@&_"Q @  X@P   T              ( !L0P  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " #W@9=8EXJ[',     3 @  "P              @ &-#P
M7W)E;',O+G)E;'-02P$"% ,4    " #W@9=8JL0B%C,!   B @  #P
M        @ %V$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ]X&76"0>
MFZ*M    ^ $  !H              ( !UA$  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ ]X&76&60>9(9 0  SP,  !,
M     ( !NQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&!10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2412326d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tactilemedical.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  tm2412326d1_8k.htm 22</Log>
  </Logs>
  <InputFiles>
    <File>tcmd-20240423.xsd</File>
    <File>tcmd-20240423_lab.xml</File>
    <File>tcmd-20240423_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2412326d1_8k.htm">tm2412326d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2412326d1_8k.htm": {
   "nsprefix": "TCMD",
   "nsuri": "http://tactilemedical.com/20240423",
   "dts": {
    "schema": {
     "local": [
      "tcmd-20240423.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "tcmd-20240423_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tcmd-20240423_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2412326d1_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://tactilemedical.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2412326d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2412326d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001104659-24-050589-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-050589-xbrl.zip
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M,DRD]N&[5N9L9C?M5!.Y+@BB=TTWK6E:ESONS=]$DLD]S_AFLV7E71[;<X.
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MV,X=4TD"PL/FJR.#C$!:ZX6%Q093^GF;)HRD\$1DJ-RR8+789*$A"8@%FR^
MA5R*M-8+"Y<;(M9R>OM)\-?LL<S/"K8-4+MEH]-RDQ&K-"!6NOP!S.@05,3H
ME+I^X-D=$HH761;AEEJDCK$!S1K,M'0A 0.9:]%"2:2NM]SP#"TY^IH2E#T2
M=%G^#%T]$WQ1CZ]?&HDB]4)$L2IG,18VA+K$SG]U!#3<^NV1EC((D'KMP;]#
M4D4@'>*8FEO)L*B?Q^4FYAG9@&\[](>X(FBH><U1GSX(F@::-)G*PYHGUWD@
M4I$^LQG5D]O#2[R&R/'*V&+06!C7%$$P MJ"EL7UWPKPDSMONZ))=$4YAJ^R
M-#2.,^:U[1G)\@Z"@ AHNX)2Y.5"E"N]]/]GS)[$]CF+]G>"1X2HIZS2:K3J
MN_XV,-HM,V]J4I.F0:$!<?86OP"!ARI0K8X/M1G+Y\4\]="XRN;&HZ?%(Y8'
M\':;I6H&E<;@J^"=08YO+PQH@'&3H2,B(/0&V(1N..21* _]@(I@5(OV='Z6
M'K( DOCS_IX\$*'>.UB27?99[NBIXPQC0*SKL[?!S3%/YGH#@X#PK6ZA4[T4
MU2M *_6,6%D%^EU5@O):;+]?7M]T+3_)S7J3_&N%4R*W_!=02P,$%     @
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M"\%[W+8RW/@!>R(\#5!"M-6_0]#G(N"'D5;;7W75]N=A!BA!4T +A3%#36,
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M>( B&1O@_\$PH5!#;'VHR>T0>\(4]L0%_2:J;235@)$$5I?@H]ACQ)RT)\Z
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M3*<VY";=]585YN!SFBM28_A<J#J3J-P\)K 7VMS0Y\3HY %6!(+ >K",#B6
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M*YLGSY*B9OX7^H>DX8L.@V4C])_>H17^28?&8>KPVA@=);['<@>?T0QJK&%
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MV_-6ZKOPEY4_]=:5]A/0%..A7)A5@ORDVVD3<8TD'L/>/0&-;!''4UPP*+Z
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MKJ)C,*5R7@U)P\*.H/.?S\><0956717DX;8Z-BG%P"I9%\.18G-4_(PYLQ+
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MRQMN+\(2?.?^!M=O[P[EC.JYNPI8D5=3K!P3$V"N2M,J,>Z>RQH#-V-ZVM%
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M\PE)6U/XH^Y(Q[>$Z%ID7[A'>"UIWD#K64()LDCYB#O!5(UF7K>#,JA4*>+
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M,R#HKRUNIX0AZ]"GDCBW9_"IKHA#[5;CAJ(NNP_Z:RK09^GXPTNO%X;YP6V
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MD M!=N/U%0-THN1GH&;&!-$/FN/SVG"'<N! 25ER^B_@G%,QT;\P)EQ#.;,
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MANJA4#9O#(&T<*+B<L/,EF]-MF3M#DXM03)$Y9^P)PB50 (8">LA*?N:0!O
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MW1 .[)P;P ';R"T_D#N52QG&$390[  9G3>G[B"YZ]QN!:$(25ZD3/',<4^
M@+RWD(K+;/+>NG.,10A+%7ME%?\*"*5SPZG4\JK%LA:Z40CP9] *I,&A0',?
MYMZF$F#:$U-DAC07;[;5?2GV1;FDH'..H.MXI$DN!36.G(M"#O<T=?R(*DNS
MX#M/50;]U5IC+96G"C$Q'G <4GT(Z)RR70SW\]2&8YN,4&T(N >H$N^V]U\^
M Z98& <SBT4QFWN6U-6@S=ARQ'(U]J@L0/7$3,^I'-FS8*X$7\[J621^2 9N
M:C9!NZ@)>P*9] C,.$N?>BH$\YP*T9/">#TDQV;F65C@4]0.N$S7=HX ( .<
M$K?_;J>.8PD-**1MPLNSF4[5_RP<D+0EQ$46&K<&=)CSFR G-!#H)*L CNLO
MIZ*=<L#-O#NHG,^FKW,<D] V-FJB+"L>C(S7,$;V8>G9XTS5/&B>$DV\PN\L
M&=92:;0X7*D$ #=%$8"-5>.QL;9J!;/9$*;>0CRY&MR4C<1-K^>-F_77LGOA
M<8VXV0MKM'^K%+_;H0GUS'HE:V<RS>[Q \6UEKS;YDB/@/$[W<[Y].,Y*\*.
MJ=7!6U&_JX^U]$9U7#M858%R7>7J9=%$BZ3D"A5<C<FT_Y[*)0A1-L%HE&+:
M:A8F T>T(M63RNPN<)=&$!ZD65=::-P0031:)(0^X1PI5T3JS4IJ)6LV_=QQ
M$7WT[[?GXW?BYORGU^/;33]RCV@BS;Q[<J'W2LYAX9X(E>%&$444' 6^80(%
M=SL(,@@_>:QP8N?0<5G<+(J0;&>- <Z<RH#[V#)/O3$TLO6R 5,LVT"4(@=+
MFT"LM&C!E=AT\5N?.NM!TU7P_4.SD@K7N7"N >X):3"W<.G23H,?ELIJ0^".
MB@9QY3!:TW,C&1IDLZ**7*LE%-"CI@!1EW_A1)=U 'YJ2BA'6<[+Z@,]-U6A
MJ:KSU>@6(;FQW0+B\-NJ/G$O3>%KJBG=CIO3*.W$05DAKQD !6'6W/K[/J:L
M7C?\9-4T<%.7J^LP%%.U!JN6<F-?7\+Q;$[VN/^EL\?/6JXY^%:N^5:N^4H'
M;O,*-7\(*3SN=E(9;#F$UE"C+5O'6'!=V&)GVWL0,_2J8.""=U&J=YA"44T^
MC@E-4^F? L52..$;1\T,P";T5<]@M23A,LZ6[ 'C[ 5H;HTM$,"!X1?N_C^C
M=U6T('RZR@02#OYRB_UWXVN,V"TA3-$O? SH%BN8VV;8?T[0_>;\EMSMX')T
M]7;#\7:KHSY#LEZGVY]ZD0H7AQ^CO!(D*'T&J"KS9\) R$[MW5G"MJ&D-JB[
MZ<](A\V,P-%#U;)4WL%XBJ2R:"Q%'M]%7SDI/-WD5!"5 5D6YPE\,Z7HZ<'&
M-*Q5ZIS**[!#>K%2P;.(,U#&SVWUI16++[%C2W!MI39J(<(_K;_N5?%L[P,
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M:3V(M<X#"9=S+"1\?K5.$X9@M-+.&# N.-RLM.WO;<43A/J]*+KEQA@!&SL
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M%9?$2+P(1][>K55_WN<&UQ4<$#/7<*&<9];-\AI[N/=.>;J@J I'35D!.<1
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MNP#PD))^2K^R['^'F7[5^?\ 4$L! A0#%     @ ]X&76!L[Q(HN P  ]0L
M !$              ( !     '1C;60M,C R-# T,C,N>'-D4$L! A0#%
M  @ ]X&76*%$FA_]"@  @(8  !4              ( !70,  '1C;60M,C R
M-# T,C-?;&%B+GAM;%!+ 0(4 Q0    ( />!EUB/%;X86P<  .%7   5
M          "  8T.  !T8VUD+3(P,C0P-#(S7W!R92YX;6Q02P$"% ,4
M" #W@9=8B>9&W_T@  ""LP  $@              @ $;%@  =&TR-#$R,S(V
M9#%?.&LN:'1M4$L! A0#%     @ ]X&76#52)*GV"   ]B8  !8
M     ( !2#<  '1M,C0Q,C,R-F0Q7V5X,3 M,2YH=&U02P$"% ,4    " #W
M@9=80-9DA08V  "V10$ %@              @ %R0   =&TR-#$R,S(V9#%?
M97@Q,"TR+FAT;5!+ 0(4 Q0    ( />!EUC*IZP&6P\  (5'   6
M      "  :QV  !T;3(T,3(S,C9D,5]E>#$P+30N:'1M4$L! A0#%     @
M]X&76#ZC!/M6$0  \3P  !8              ( !.X8  '1M,C0Q,C,R-F0Q
A7V5X.3DM,2YH=&U02P4&      @ "  5 @  Q9<

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>tm2412326d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tcmd-20240423.xsd" xlink:type="simple"/>
    <context id="AsOf2024-04-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001027838</identifier>
        </entity>
        <period>
            <startDate>2024-04-23</startDate>
            <endDate>2024-04-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-04-23" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-04-23" id="Fact000004">0001027838</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="AsOf2024-04-23" id="xdx2ixbrl0012">TACTILE SYSTEMS TECHNOLOGY INC</dei:EntityRegistrantName>
    <dei:DocumentType contextRef="AsOf2024-04-23" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-04-23" id="Fact000011">2024-04-23</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-04-23" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-04-23" id="Fact000014">001-37799</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-04-23" id="Fact000015">41-1801204</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-04-23" id="Fact000016">3701 Wayzata Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-04-23" id="Fact000017">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-04-23" id="Fact000018">Minneapolis</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-04-23" id="Fact000019">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-04-23" id="Fact000020">55416</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-04-23" id="Fact000021">612</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-04-23" id="Fact000022">355-5100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-04-23" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-04-23" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-04-23" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-04-23" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-04-23" id="Fact000027">Common     Stock, Par Value $0.001 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-04-23" id="Fact000028">TCMD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-04-23" id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-04-23" id="Fact000030">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
